↓ Skip to main content

Dove Medical Press

Dasatinib in chronic myeloid leukemia: a review

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (91st percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

news
1 news outlet
patent
1 patent
wikipedia
1 Wikipedia page

Citations

dimensions_citation
78 Dimensions

Readers on

mendeley
116 Mendeley
Title
Dasatinib in chronic myeloid leukemia: a review
Published in
Therapeutics and Clinical Risk Management, March 2009
DOI 10.2147/tcrm.s3425
Pubmed ID
Authors

Dolly G Aguilera, Apostolia M Tsimberidou

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 116 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 <1%
India 1 <1%
Unknown 114 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 24 21%
Student > Bachelor 21 18%
Student > Ph. D. Student 14 12%
Researcher 9 8%
Student > Postgraduate 8 7%
Other 14 12%
Unknown 26 22%
Readers by discipline Count As %
Medicine and Dentistry 27 23%
Biochemistry, Genetics and Molecular Biology 18 16%
Agricultural and Biological Sciences 16 14%
Chemistry 9 8%
Pharmacology, Toxicology and Pharmaceutical Science 8 7%
Other 13 11%
Unknown 25 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2023.
All research outputs
#2,655,593
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#122
of 1,323 outputs
Outputs of similar age
#8,450
of 108,601 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#2
of 6 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 108,601 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one. This one has scored higher than 4 of them.